Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-024881

Options or other derivatives

  • Chief Operations Officer acquired 192,143 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Dagnon Terry Chief Operations Officer 2023-04-17 Grant or award · Stock Option (Right to Buy) +192,143 192,143 D: show line 1 in the form
Loading xslF345X04/doc4.xml…